These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3486421

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Frequency of HPRT mutant lymphocytes in a human control population as determined by the T-cell cloning procedure.
    Hüttner E, Holzapfel B, Kropf S.
    Mutat Res; 1995 Oct; 348(2):83-91. PubMed ID: 7477056
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A novel class of unstable 6-thioguanine-resistant cells from dog and human kidneys.
    Turker MS, Monnat RJ, Fukuchi K, Johnston PA, Ogburn CE, Weller RE, Park JF, Martin GM.
    Cell Biol Toxicol; 1988 Jun; 4(2):211-23. PubMed ID: 3233532
    [Abstract] [Full Text] [Related]

  • 26. An enumerative assay of purine analogue resistant lymphocytes in women heterozygous for the Lesch-Nyhan Mutation.
    Strauss GH, Allen EF, Albertini RJ.
    Biochem Genet; 1980 Jun; 18(5-6):529-47. PubMed ID: 7437011
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.
    O'Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ.
    Mutagenesis; 1987 Mar; 2(2):87-94. PubMed ID: 3331707
    [Abstract] [Full Text] [Related]

  • 31. Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.
    Albertini MR, Macklin MD, Zuleger CL, Newton MA, Judice SA, Albertini RJ.
    Environ Mol Mutagen; 2008 Dec; 49(9):676-87. PubMed ID: 18712786
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the severity of hypoxanthine-guanine phosphoribosyltransferase deficiency using viable T cells.
    Yamanaka H, Kamatani N, Nishoka K, Kobayashi M, Wada Y, Ohtani T, Mikanagi K.
    Hum Hered; 1985 Dec; 35(6):358-63. PubMed ID: 3876977
    [Abstract] [Full Text] [Related]

  • 33. A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMS.
    Knaap AG, Simons JW.
    Mutat Res; 1975 Oct; 30(1):97-110. PubMed ID: 1237086
    [Abstract] [Full Text] [Related]

  • 34. Expression of transformation in cell hybrids. I. Isolation and application of density-inhibited Balb/3T3 cells deficient in hypoxanthine phosphoribosyltransferase and resistant to ouabain.
    Jha KK, Ozer HL.
    Somatic Cell Genet; 1976 May; 2(3):215-23. PubMed ID: 1028169
    [Abstract] [Full Text] [Related]

  • 35. Longitudinal study of the in vivo hprt mutant frequency in human T-lymphocytes as determined by a cell cloning assay.
    O'Neill JP, Sullivan LM, Booker JK, Pornelos BS, Falta MT, Greene CJ, Albertini RJ.
    Environ Mol Mutagen; 1989 May; 13(4):289-93. PubMed ID: 2786809
    [Abstract] [Full Text] [Related]

  • 36. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
    Yamashina K, Miller BE, Heppner GH.
    Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067
    [Abstract] [Full Text] [Related]

  • 37. Recovery of V79 cell clones with different phenotypes in aminopterin- or azaserine-containing media used for the selection of HGPRT revertants.
    Randazzo R, Bonatti S, Luccarini G, Abbondandolo A.
    Mutat Res; 1984 May; 126(3):273-7. PubMed ID: 6717463
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficiency of isolation of revertible 6-thioguanine resistant clones is dependent on the concentration of thioguanine used for selection.
    Fox M.
    Carcinogenesis; 1981 May; 2(9):941-4. PubMed ID: 7296775
    [Abstract] [Full Text] [Related]

  • 40. The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea.
    Aidoo A, Lyn-Cook LE, Heflich RH, George EO, Casciano DA.
    Mutat Res; 1993 Jan; 298(3):169-78. PubMed ID: 7678151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.